Serna, Garazi
Ruiz-Pace, Fiorella
Cecchi, Fabiola
Fasani, Roberta
Jimenez, Jose
Thyparambil, Sheeno
Landolfi, Stefania http://orcid.org/0000-0002-1059-635X
Elez, Elena
Vivancos, Ana
Hembrough, Todd
Tabernero, Josep http://orcid.org/0000-0002-2495-8139
Dienstmann, Rodrigo
Nuciforo, Paolo http://orcid.org/0000-0003-1380-0990
Article History
Received: 14 May 2019
Accepted: 30 August 2019
First Online: 19 September 2019
Competing Interests
: JT reports personal financial interest in form of scientific consultancy role for Array Biopharma, AstraZeneca, Bayer, BeiGene, Boehringer Ingelheim, Chugai, Genentech, Inc., Genmab A/S, Halozyme, Imugene Limited, Inflection Biosciences Limited, Ipsen, Kura Oncology, Lilly, MSD, Menarini, Merck Serono, Merrimack, Merus, Molecular Partners, Novartis, Peptomyc, Pfizer, Pharmacyclics, ProteoDesign SL, Rafael Pharmaceuticals, F. Hoffmann-La Roche Ltd, Sanofi, SeaGen, Seattle Genetics, Servier, Symphogen, Taiho, VCN Biosciences, Biocartis, Foundation Medicine, HalioDX SAS and Roche Diagnostics. ST own stocks in Nantomics. FC and TH own stocks in Nantomics and AstraZeneca. PN has consulted for Bayer, Novartis, and MSD and received compensation.